Home / Brands / PharMEDium Services
PharMEDium Services Recalls
291 recalls on record · September 2, 2015 to April 15, 2020 · Drugs
Recalls by year
15
16
17
18
19
20
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls fentaNYL Citrate, 5 mcg per mL, 15 mcg per 3mL, in 0.9% Sodium chloride, 3 mL Total Volume in a syringe, For IV Use, Rx
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls fentaNYL Citrate Injection, 50 mcg per mL, 250 mcg per 5 mL, 5mL Total Volume in a syringe, For IV Use, Rx only, PharMED
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls fentaNYL Citrate Injection, 50 mcg per mL (100 mcg per 2 mL), 2 mL Total Volume in a syringe, For IV Use, Rx only, PharM
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls fentaNYL Citrate, 25 mcg per mL in 0.9% Sodium chloride, 1 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls fentaNYL Citrate, 10 mcg per 1 mL, in 0.9% Sodium Chloride, Preservative Free, 1 mL Total Volume in a syringe, For IV Us
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls fentaNYL Citrate Injection, 50 mcg per mL, Preservative Free, 1 mL Total Volume in a syringe, For IV Use, Rx only, PharM
Hazard: Subpotent Drug and Stability Data Does Not Support Expiry: confirmed subpotency and potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls fentaNYL Citrate Injection, 50 mcg per mL, Preservative Free, 1 mL Total Volume in a syringe, For IV Use, Product code 2
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls Fentanyl Citrate 16.67 mcg per mL and Bupivacaine HCl 0.1667% in 0.9% Sodium Chloride, Total Dose 25.005 mcg/1.5 mL Fent
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls ePHEDrine Sulfate, 10 mg per mL, in 0.9% Sodium Chloride, Preservative Free, 1 mL Total Volume in a syringe, For IV Use,
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls ePHEDrine Sulfate, 10 mg per mL, 50 mg per 5 mL, in 0.9% Sodium Chloride, Preservative Free, 5 mL Total Volume in a syr
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls ePHEDrine Sulfate, 5 mg per mL, 25 mg per 5 mL, in 0.9% Sodium Chloride, Preservative Free, 5 mL Total Volume in a syrin
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls Buffered Lidocaine, 2%, In Sodium Bicarbonate 8.4%, 3 mL Total Volume in a syringe, Local anesthetic use, Rx only, PharM
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls Buffered Lidocaine, 1%, In Sodium Bicarbonate 8.4%, 1 mL Total Volume in a syringe, Local anesthetic use, Rx only, PharM
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls atropine Sulfate Injection, 0.4 mg per mL, 0.8 mg per 2 mL, 2 mL Total Volume in a syringe, For IV Use, Rx only, PharMED
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
October 19, 2016DrugsFDA
Pharmedium Services, LLC recalls atropine Sulfate Injection, 0.4 mg per mL, 1 mg per 2.5 mL, 2.5 mL Total Volume in a syringe, For IV use, Rx only, PharM
Hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 8 mcg/mL HYDROmorphone HCl and 0.05% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Hospi
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 6.66 mcg/mL Fentanyl Citrate and 0.22% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 15 mL in 20 mL BD Sy
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 6.66 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 15 mL in 20 mL BD S
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL HYDROmorphone HCl and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 50 mL in 60 mL BD Syr
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 200 mL in 250 mL Hospir
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL HYDROmorphone HCl and 0.075% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 ml Hosp
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Bax
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL Fentanyl Citrate and 0.25% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Smith
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride 50 mL in 60 mL BD Syrin
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 50 mL in 60 mL BD Syring
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 250 mL in 250 mL Hospi
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride Service Code 2K8135
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL Fentanyl Citrate and 0.05% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Hospir
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 5 mcg/mL Fentanyl Citrate and 0.04% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Yellow
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
July 27, 2016DrugsFDA
Pharmedium Services, LLC recalls 4 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 100 mL in 100 mL Yello
Hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.